Abstract

Abstract Already in 1939 and 1945 it had been demonstrated that tumours induce the formation of new capillaries from preexisting blood vessels, a process termed angiogenesis (1,2). Subsequently, it was shown that soluble angiogenic factors released by tumours were responsible for this process (3,4). The finding that many of these growth factors bound to heparin allowed the purification and classification of a family of heparin-binding growth factors (5). The prototypes of this family are fibroblast growth factor (FGF) 1 and FGF-2, and they have been studied in great detail in many physiological and pathological processes (reviewed in references 6-10). To date the family has expanded to nine distinct, but closely related family members. Based on their pattern of expression and their biological activities they are thought to be involved in many physiological and pathological processes, including embryonic development, differentiation, cell survival, angiogenesis, oncogenic transformation, and tumour cell proliferation.

Keywords

AngiogenesisFibroblast growth factorBiologyPathologicalCancer researchCell biologyEmbryonic stem cellCell growthFibroblastHeparinBasic fibroblast growth factorGrowth factorImmunologyPathologyMedicineCell cultureGeneticsBiochemistryReceptorGene

Related Publications

Publication Info

Year
1997
Type
book-chapter
Pages
201-238
Citations
13
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

13
OpenAlex
11
CrossRef

Cite This

Gerhard Christofori (1997). The role of fibroblast growth factors in tumour progression and angiogenesis. Tumour Angiogenesis , 201-238. https://doi.org/10.1093/oso/9780198549376.003.0017

Identifiers

DOI
10.1093/oso/9780198549376.003.0017

Data Quality

Data completeness: 77%